Literature DB >> 11267139

TP20 is superior to TP10 in reducing ischemia/reperfusion injury in rat lung grafts.

R A Schmid1, S Hillinger, J Hamacher, U Stammberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267139     DOI： 10.1016/s0041-1345(00)02279-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

2.  Progress and Trends in Complement Therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

3.  Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion.

Authors:  Bart P Van Putte; Jozef Kesecioglu; Jeroen M H Hendriks; Veerle P Persy; Erik van Marck; Paul E Y Van Schil; Marc E De Broe
Journal:  Crit Care       Date:  2004-11-10       Impact factor: 9.097

Review 4.  Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease.

Authors:  Esther C W de Boer; Anouk G van Mourik; Ilse Jongerius
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

Review 5.  Halting targeted and collateral damage to red blood cells by the complement system.

Authors:  M Jalink; E C W de Boer; D Evers; M Q Havinga; J M I Vos; S Zeerleder; M de Haas; I Jongerius
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

Review 6.  Complement, a target for therapy in inflammatory and degenerative diseases.

Authors:  B Paul Morgan; Claire L Harris
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 112.288
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.